recombinant human interferon gamma receptor antagonists (Tigo)

N/A

Report date: 2025/03/20 10:01:59

Base Information

Drug Namerecombinant human interferon gamma receptor antagonists (Tigo)
Drug Alias NamehIFN-g RA (TIGO)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterferon gamma receptor antagonists
TargetsInterferon gamma receptor
Therapy Area/IndicationsArteriosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTIGO GmbH
China Registration ClassN/A

Develop Information

Active CompaniesTIGO GmbH
Inactive CompaniesN/A
Active IndicationsArteriosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A